| Literature DB >> 33925225 |
Min-Young Chun1,2, Jeong-Hoon Kim3, Ju-Seop Kang2.
Abstract
The importance of sleep has been gaining more and more attention nowadays. It has been widely studied that some major health issues, such as cardiovascular diseases or mortality, are closely related to the extreme ends of sleep durations. Anemia is one of the health problems in modern society. In this study, we aimed to find a relationship between anemia occurrence and sleep duration. Data of 11,131 Korean adults aged 19 years or older were recruited from the 2016-2017 Korea National Health and Nutrition Examination Survey and analyzed in this cross-sectional study. 'Anemia' was defined in this study by hemoglobin level of <13 g/dL in men and <12 g/dL in women. Selected data were sorted into five groups by sleep duration: <5 h, 5 h ~ <6 h, 6 h ~ <8 h, 8 h ~ <9 h, and ≥9 h per day. We performed multivariate logistic regression analysis to assess the relationship between sleep duration and risk of anemia after adjusting for covariates including age, gender, family income level, education level, physical activity, cigarette smoking, and alcohol usage. Other factors were assessed in the analysis, such as depression, hypertension, diabetes, dyslipidemia, stroke, coronary artery disease, malignancy, stress level, and body mass index (BMI). We found that sleep duration of <5 h was related to high risk of anemia (odds ratio = 1.87; 95% confidence interval = 1.01-3.49, sleep duration of 6 h ~ <8 h as the reference group). Also, sleep duration of ≥9 h was related to lower risk of anemia in most premenopausal women after adjusting for covariates (odds ratio = 0.61; 95% confidence interval = 0.38-0.96, sleep duration of 6 h ~ < 8 h as the reference group). Male individuals with sleep durations of <5 h (odds ratio = 2.01; 95% confidence interval =1.05-3.84) and of ≥9 h (odds ratio = 2.48; 95% confidence interval =1.63-3.81) had a significantly higher risk of anemia without covariate adjustment. Postmenopausal women with sleep durations of ≥9 h had a significantly higher risk of anemia (odds ratio =2.02; 95% confidence interval =1.33-3.08) without adjusting for covariates. However, the associations became statistically insignificant after adjusting for age and covariates in both men and postmenopausal women. In conclusion, we found significant associations between extreme ends of sleep duration and risk of anemia in premenopausal Korean women. However, we did not observe strong associations between self-reported sleep duration and anemia risk in men or postmenopausal women.Entities:
Keywords: Korean population; anemia; premenopausal women; sleep duration
Year: 2021 PMID: 33925225 PMCID: PMC8124661 DOI: 10.3390/ijerph18094721
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flowchart showing inclusion and exclusion of subjects according to study criteria.
Demographics of the study participants according to sleep duration.
| Variable | Sleep Duration (hours) | |||||
|---|---|---|---|---|---|---|
| <5 h | 5 h ~ <6 h | 6 h ~ <8 h | 8 h ~ <9 h | ≥9 h | ||
| Questionnaire-Based Data | ( | ( | ( | ( |
( | |
| Age, years | 47.12 ± 1.04 ab | 47.76 ± 0.59 ab | 46.28 ± 0.3 a | 46.88 ± 0.48 a | 48.88 ± 0.82 bc | 0.002 |
|
male, sex, | 206 (47.7) ab | 461 (46.5) a | 2821(52.7) b | 950(47.4) ab | 476(45.7) a | <0.001 |
|
Family income,
| ||||||
| Low | 134 (23.5) | 220 (16.0) | 940 (12.5) | 435 (16.1) | 380 (28.4) | <0.001 |
| Lower middle | 123 (24.6) | 269 (23.0) | 1433 (22.1) | 579 (24.5) | 284 (23.5) | |
| Upper middle | 135 (30.4) | 308 (28.9) | 1760 (30.8) | 602 (29.0) | 268 (26.4) | |
| High | 99 (21.5) | 331 (32.1) | 1997 (34.6) | 604 (30.4) | 201 (21.6) | |
|
High school or above
, | 316 (72.8) ab | 804 (78.0) b | 4603 (81.3) b | 1514 (76.1) ab | 630 (66.3) a | <0.001 |
|
Current smoker
, | 103 (24.0) a | 217 (21.4) a | 1158 (22.8) b | 363 (19.6) a | 197 (21.6) a | 0.043 |
|
Frequency of alcohol intake/month,
| ||||||
| Never | 103 (21.7) | 182 (15.4) | 895 (13.4) | 336 (14.4) | 221 (18.6) | 0.021 |
| Less than once | 108 (27.9) | 314 (31.4) | 1768 (30.9) | 637 (31.9) | 299 (30.6) | |
| Two– four times | 86 (21.0) | 260 (26.8) | 1456 (28.8) | 497 (28.0) | 204 (23.4) | |
| Over four times | 115 (29.4) | 248 (26.4) | 1417 (26.9) | 472 (25.7) | 244 (27.3) | |
|
Aerobic regular exercise, | 211 (45.9) ab | 512 (49.0) a | 2849 (49.0) a | 941 (46.4) ab | 388 (39.5) b | <0.001 |
|
High stress or above
, | 47 (10.5) a | 56 (5.0) bc | 273 (4.3) c | 93 (4.6) b | 54 (5.4) b | <0.001 |
| Depression, | 37 (7.5) a | 50 (4.0) ab | 241 (3.5) b | 95 (3.9) b | 63 (5.1) ab | <0.001 |
| Hypertension, | 143 (24.5) a | 284 (20.1) ab | 1325 (17.4) b | 576 (19.6) ab | 352 (24.7) a | <0.001 |
| Diabetes mellitus, | 62 (10.0) a | 99 (7.5) ab | 551 (7.2) b | 223 (7.8) ab | 148 (9.8) a | 0.026 |
| Dyslipidemia, | 107 (20.2) | 215 (15.5) | 1059 (14.9) | 420 (15.7) | 198(14.7) | 0.071 |
| Stroke, | 7 (0.8) a | 18 (1.5) a | 113 (1.4) a | 63 (2.0) a | 44 (3.4) b | <0.001 |
| MI or Angina, | 12 (1.4) ab | 19 (1.1) a | 105 (1.3) ab | 55 (2.0) b | 31 (2.3) b | 0.010 |
| Cancer, | 12 (1.7) | 17 (1.3) | 128 (1.7) | 47 (1.8) | 30 (2.1) | 0.667 |
| Exam-Based Data | ||||||
| BMI (kg/m2) | 24.70 ± 0.22 a | 24.28 ± 0.11 b | 23.95 ± 0.06 b | 23.80 ± 0.10 bc | 23.58 ± 0.13 c | <0.001 |
| HbA1c (%) | 5.80 ± 0.06 a | 5.69 ± 0.03 b | 5.61 ± 0.01 b | 5.63 ± 0.02 b | 5.66 ± 0.03 ab | 0.002 |
| Total cholesterol (mg/dL) | 197.36 ± 2.16 | 194.71 ± 1.15 | 193.29 ± 0.60 | 192.80 ± 0.88 | 191.77 ± 1.36 | 0.159 |
| HDL-cholesterol | 51.67 ± 0.65 | 51.35 ± 0.48 | 51.26 ± 0.21 | 50.92 ± 0.29 | 50.65 ± 0.43 | 0.522 |
| Triglycerides | 154.23 ± 10.72 | 139.81 ± 4.45 | 138.73 ± 2.86 | 138.73 ± 2.86 | 138.91 ± 3.31 | 0.708 |
| LDL-cholesterol | 121.59 ± 4.53 | 121.52 ± 3.02 | 118.59 ± 1.35 | 118.50 ± 2.36 | 120.88 ± 3.20 | 0.837 |
| Hemoglobin (g/dL) | 14.16 ± 0.10 a | 14.12 ± 0.06 a | 14.29 ± 0.03 b | 14.16 ± 0.04 a | 14.06 ± 0.06 a | <0.001 |
| hs-CRP (mg/L) | 1.27 ± 0.10 | 1.16 ± 0.06 | 1.14 ± 0.03 | 1.21 ± 0.05 | 1.29 ± 0.07 | 0.162 |
Values are expressed as mean ± standard error for continuous variables and numbers (%) for categorical variables. p-values * are determined by weighted chi-square tests of categorical variables and by weighted analysis of variance of continuous variables between all groups. BMI: body mass index, HbA1c: hemoglobin A1c, HDL: high-density lipoprotein, LDL: low-density lipoprotein. hs-CRP: high-sensitivity C-reactive protein. Different superscript indicates significant (p < 0.05) post hoc pairwise difference using Tukey (for continuous variable) or Bonferroni (for categorical variable) correction.
Demographics of the study participants with anemia and without anemia.
| Variables | Anemia ( | Without Anemia ( | |
|---|---|---|---|
| Questionnaire-Based Data | |||
| Age, years | 51.55 ± 0.7 | 46.48 ± 0.23 | <0.001 |
|
male, sex, | 234 (20.0) | 4680 (52.7) | <0.001 |
|
Family income level
, | <0.001 | ||
| Low | 268 (22.2) | 1841 (15.0) | |
| Lower middle | 261 (25.8) | 2427 (22.7) | |
| Upper middle | 239 (25.4) | 2834 (30.2) | |
| High | 232 (26.6) | 3000 (32.1) | |
|
High school or above
, | 638 (70.6) | 7229 (78.8) | <0.001 |
|
Current smoker
, | 65 (6.8) | 1973 (23.3) | <0.001 |
|
Frequency of alcohol intake per month,
| <0.001 | ||
| Never | 227 (25.6) | 1510 (13.8) | |
| Less than once | 288 (37.4) | 2838 (30.5) | |
| Two– four times | 184 (23.5) | 2319 (27.9) | |
| Over four times | 122 (13.5) | 2374 (27.8) | |
|
Aerobic regular exercise, | 380(41.2) | 4521(48.0) | 0.001 |
|
High stress or above
, | 53 (5.8) | 440 (5.0) | 0.015 |
| Depression, | 56 (5.2) | 430 (3.9) | 0.038 |
| Hypertension, | 308 (25.8) | 2405 (18.9) | <0.001 |
| Diabetes mellitus, | 175 (15.1) | 905 (7.1) | <0.001 |
| Dyslipidemia, | 180(16.8) | 1819 (15.2) | 0.218 |
| Stroke, | 33 (2.7) | 212 (1.6) | 0.018 |
| MI or Angina pectoris, | 47 (3.6) | 273(2.0) | 0.001 |
|
Cancer
, | 48 (4.2) | 186 (1.5) | <0.001 |
| Exam-Based Data | |||
| BMI (kg/m2) | 22.85 ± 0.12 | 24.04 ± 0.05 | <0.001 |
| HbA1c (%) | 5.76 ± 0.03 | 5.62 ± 0.01 | <0.001 |
| Total cholesterol (mg/dL) | 181.56 ± 1.34 | 194.38 ± 0.49 | <0.001 |
| HDL-cholesterol (mg/dL) | 51.91 ± 0.51 | 51.10 ± 0.16 | 0.119 |
| Triglycerides (mg/dL) | 102.61 ± 2.33 | 142.90 ± 1.88 | <0.001 |
| LDL-cholesterol (mg/dL) | 110.92 ± 4.41 | 119.53 ± 1.04 | 0.059 |
| Hemoglobin (g/dL) | 11.14 ± 0.04 | 14.48 ± 0.02 | <0.001 |
| hs-CRP (mg/L) | 1.29 ± 0.08 | 1.17 ± 0.02 | 0.139 |
Values are expressed as mean ± standard error for continuous variables and numbers (%) for categorical variables. p-values * are determined by weighted chi-square tests of categorical variables and by weighted t-test of variance of continuous variables between two groups. BMI: body mass index, HbA1c: hemoglobin A1c, HDL: high-density lipoprotein, LDL: low-density lipoprotein. hs-CRP: high-sensitivity C-reactive protein.
Crude and adjusted odds ratios for sleep duration associated with anemia according to various statistical models.
| Sleep Duration (Hours) | |||||
|---|---|---|---|---|---|
| Total | <5 h | 5 h ~ <6 h | 6 h ~ <8 h | 8 h ~ <9 h | ≥9 h |
| Model 1 a | 1.37 (0.96–1.96) | 1.25 (0.75–1.59) | reference | 1.04 (0.85–1.28) | 1.29 (1.00–1.65) |
| Model 2 b | 1.25 (0.87–1.43) | 1.11 (0.86–1.43) | reference | 0.97 (0.79–1.19) | 1.14 (0.89–1.46) |
| Model 3 c | 1.12 (0.94–2.13) | 1.08 (0.82–1.43) | reference | 0.95 (0.75–1.19) | 1.07 (0.80–1.43) |
| Model 4 d | 1.60 (1.05–2.39) | 1.14 (0.86–1.51) | reference | 0.91 (0.72–1.15) | 1.01 (0.76–1.36) |
| Women | |||||
| Model 1 a | 1.14 (0.75–1.74) | 1.13 (0.86–1.48) | reference | 0.85 (0.68–1.07) | 0.94 (0.69–1.28) |
| Model 2 b | 1.14 (0.75–1.74) | 1.12 (0.85–1.47) | reference | 0.85 (0.68–1.01) | 0.93 (0.69–1.27) |
| Model 3 c | 1.37 (0.85–2.19) | 1.08 (0.80–1.470 | reference | 0.82 (0.64–1.06) | 0.85 (0.60–1.20) |
| Model 4 d | 1.51 (0.93–2.44) | 1.10 (0.81–1.49) | reference | 0.81(0.63–1.05) | 0.84 (0.60–1.19) |
| Men | |||||
| Model 1 a | 2.01 (1.05–3.84) | 1.23 (0.67–2.25) | reference | 1.57 (1.07–2.31) | 2.48 (1.63–3.81) |
| Model 2 b | 1.75 (0.90–3.37) | 1.23 (0.66–2.28) | reference | 1.22 (0.81–1.85) | 1.34 (0.84–2.11) |
| Model 3 c | 1.52 (0.72–3.20) | 1.29 (0.68–2.47) | reference | 1.14 (0.72–1.82) | 1.15 (0.58–1.93) |
| Model 4 d | 1.51 (0.72–3.15) | 1.49(0.78–2.87) | reference | 1.16 (0.72–1.89) | 1.06 (0.62–1.79) |
Data are presented as estimated marginal means (95% confidence intervals). Model 1 a: None of the variables are adjusted. Model 2 b: Age is adjusted. Model 3 c: Age, level of education, family income level, smoking, alcohol, and physical activity are adjusted. Model 4 d: Model 3 plus stress, depression, hypertension, diabetes mellitus, dyslipidemia, stroke, myocardial infarction or angina pectoris, and body mass index are adjusted.
Crude and adjusted odds ratios for sleep duration associated with anemia stratified menstrual status in women.
| Total | Sleep Duration (Hours) | ||||
|---|---|---|---|---|---|
| <5 h | 5 h ~ <6 h | 6 h ~ <8 h | 8 h ~ <9 h | ≥9 h | |
| Premenopausal State | |||||
| Model 1 a | 1.31 (0.72–2.38) | 1.32 (0.92–1.88) | reference | 0.89 (0.68–1.19) | 0.53 (0.35–0.83) |
| Model 2 b | 1.34 (0.72–2.47) | 1.27 (0.89–1.83) | reference | 0.92 (0.69–1.21) | 0.59 (0.38–0.92) |
| Model 3 c | 1.62 (0.87–3.05) | 1.28 (0.88–1.85) | reference | 0.86 (0.64–1.16) | 0.61 (0.38–0.96) |
| Model 4 d | 1.87 (1.01–3.49) | 1.31(0.89–1.91) | reference | 0.85 (0.63–1.45) | 0.61 (0.38–0.96) |
| Postmenopausal State | |||||
| Model 1 a | 1.13 (0.69–1.91) | 0.96 (0.59–1.57) | reference | 0.82 (0.55–1.24) | 2.02 (1.33–3.08) |
| Model 2 b | 0.96 (0.55–1.68) | 0.93 (0.56–1.52) | reference | 0.76 (0.51–1.15) | 1.51 (0.99–2.43) |
| Model 3 c | 1.12 (0.54–2.31) | 0.76 (0.42–1.39) | reference | 0.71 (0.41–1.21) | 1.49 (0.82–2.71) |
| Model 4 d | 1.10 (0.53–2.32) | 0.80 (0.43–1.49) | reference | 0.69 (0.40–1.19) | 1.51 (0.82–2.79) |
Data are presented as estimated marginal means (95% confidence intervals). Model 1 a: None of the variables are adjusted. Model 2 b: Age is adjusted. Model 3 c: Age, level of education, family income level, smoking, alcohol, and physical activity are adjusted. Model 4 d: Model 3 plus stress, depression, hypertension, diabetes mellitus, dyslipidemia, stroke, myocardial infarction or angina pectoris, and body mass index are adjusted.